Opko Health (OPK) Receivables (2010 - 2026)

Opko Health (OPK) has 17 years of Receivables data on file, last reported at $84.3 million in Q2 2026.

• Quarterly Receivables fell 16.6% year-over-year to $84.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $84.3 million (down 16.6% YoY) and the FY2025 annual result came in at $92.3 million, down 22.6% from the prior year.
• Receivables improved to $84.3 million in Q2 2026, from $81.8 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $214.7 million in Q1 2022 to a low of $81.8 million in Q1 2026.
• A 5-year average of $123.6 million and a median of $116.3 million in 2024 frame the typical range for Receivables.
• Annual changes were most pronounced in 2022 — Receivables slumped 49.72% — and 2023, when it climbed 28.93%.
• Tracing OPK's Receivables over 5 years: stood at $131.5 million in 2022, then fell by 4.64% to $125.4 million in 2023, then retreated by 4.86% to $119.3 million in 2024, then slipped by 22.6% to $92.3 million in 2025, then slipped by 8.72% to $84.3 million in 2026.
• The last three Receivables figures came in at $84.3 million (Q2 2026), $81.8 million (Q1 2026), and $92.3 million (Q4 2025), per Business Quant data.